Clinical Trial: 21369

Trial Status: Open
Disease Type: Gynecologic
Trial ID 21369
Sponsor ID PICCOLO

PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression

Principal Investigator
Robert L. Marsh, MD
3 Locations

Locations

Arlington Office

Fairfax Office

Gainesville Office

Learn More About This Trial

Other Relevant Trials
Trial ID 21308
Sponsor ID Zentalis Pharmaceuticals

A Phase 1/2 Dose-Escalation and Dose-Expansion Study of ZN‑c3 in Combination with Niraparib in Subjects with Platinum-Resistant Ovarian Cancer

1 Location
Trial ID 21253
Sponsor ID FLORA-5

A Phase 3, Double-Blind, Placebo-Controlled, Multicenter Clinical Study comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin-Oregovomab) versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) in Patients with Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma(FLORA-5)

Principal Investigator
Robert L. Marsh, MD
3 Locations